NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 25 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 868,699 | $4,161,000 | 1.03% |
| Greenlight Capital | 2,727,027 | $13,062,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 345,500 | $1,655,000 | 0.55% |
| GSA CAPITAL PARTNERS LLP | 346,151 | $1,658,000 | 0.19% |
| Tibra Equities Europe Ltd | 66,400 | $318,000 | 0.10% |
| Opal Wealth Advisors, LLC | 20,000 | $96,000 | 0.09% |
| Stonepine Capital Management, LLC | 31,070 | $149,000 | 0.08% |
| Frontier Wealth Management LLC | 145,000 | $695,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,490,000 | 0.04% |
| PERKINS CAPITAL MANAGEMENT INC | 14,800 | $71,000 | 0.04% |